Key result
Valve surgery is linked to ~76% lower 1-year mortality versus no surgery in older infective endocarditis.
Why the study?
Data on management and benefits of surgery for infective endocarditis in patients aged 80 years and older are sparse and unclear.
Does valve surgery reduce 1-year mortality in patients aged ≥ 80 years with left-sided infective endocarditis and surgical indications?
Cohort (n=163)
Does valve surgery reduce 1-year mortality in patients aged ≥ 80 years with left-sided infective endocarditis and surgical indications?
Valve surgery improves 1-year survival in octogenarians with left-sided infective endocarditis, but this benefit is limited to those with good baseline functional status.
BACKGROUND: Infective endocarditis (IE) is increasingly affecting older patients. However, data on their management are sparse, and the benefits of surgery in this population are unclear. METHODS: We included patients with left-sided IE (LSIE) aged ≥ 80 years enrolled in a prospective endocarditis cohort managed in Aquitaine, France, from 2013 to 2020. Geriatric data were collected retrospectively to identify factors associated with the 1-year risk of death using Cox regression. RESULTS: We included 163 patients with LSIE (median age, 84 years; men, 59%; rate of prosthetic LSIE, 45%). Of the 105 (64%) patients with potential surgical indications, 38 (36%) underwent valve surgery: they were younger, more likely to be men with aortic involvement, and had a lower Charlson comorbidity index. Moreover, they had better functional status at admission (ie, the ability to walk unassisted and a higher median activities of daily living [ADL] score; n = 5/6 vs 3/6, P = .01). The 1-year mortality rate in LSIE patients without surgical indications was 28%; it was lower in those who were operated on compared with those who were not despite a surgical indication (16% vs 66%, P < .001). Impaired functional status at admission was strongly associated with mortality regardless of surgical status. In patients unable to walk unassisted or with an ADL score <4, there was no significant surgical benefit for 1-year mortality. CONCLUSIONS: Surgery improves the prognosis of older patients with LSIE and good functional status. Surgical futility should be discussed in patients with altered autonomy. The endocarditis team should include a geriatric specialist.
No takes yet. Share an insight, caveat, or question.
Hémar et al. (2023) conducted a cohort in Left-sided infective endocarditis (n=163). Valve surgery vs. No surgery despite surgical indication was evaluated on 1-year mortality (p=<.001). Valve surgery was associated with lower 1-year mortality compared to no surgery in older patients with left-sided infective endocarditis and a surgical indication (16% vs 66%, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: